Aranesp and Pain disorder - a phase IV clinical study of FDA data

Summary:

Pain disorder is found among people who take Aranesp, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Aranesp and have Pain disorder. It is created by eHealthMe based on reports of 50,679 people who have side effects when taking Aranesp from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 29, 2023

50,679 people reported to have side effects when taking Aranesp.
Among them, 17 people (0.03%) have Pain disorder.

What is Aranesp?

Aranesp has active ingredients of darbepoetin alfa. It is often used in anemia. eHealthMe is studying from 50,791 Aranesp users for its effectiveness, alternative drugs and more.

What is Pain disorder?

Pain disorder is found to be associated with 416 drugs and 246 conditions by eHealthMe.

Number of Aranesp and Pain disorder reports submitted per year:

Gender of people who have Pain disorder when taking Aranesp *:

female: 94.12 %
male: 5.88 %

Age of people who have Pain disorder when taking Aranesp *:

Common drugs people take besides Aranesp *:

Common side effects people have besides Pain disorder *:

Weakness: 17 people, 100.00%
Osteomyelitis (infection of bone): 17 people, 100.00%
Osteitis (a general term for inflammation of bone): 17 people, 100.00%
Oral Pain: 17 people, 100.00%
Oedema (fluid collection in tissue): 17 people, 100.00%
Nausea And Vomiting: 17 people, 100.00%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 17 people, 100.00%
Lumbar Spinal Stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone): 17 people, 100.00%
Limb Discomfort (discomfort in leg): 17 people, 100.00%
Joint Pain: 17 people, 100.00%

Common conditions people have *:

Pain: 17 people, 100.00%
Multiple Myeloma (cancer of the plasma cells): 17 people, 100.00%
Limb Discomfort (discomfort in leg): 17 people, 100.00%
Acute Kidney Failure: 8 people, 47.06%

* Approximation only. Some reports may have incomplete information.

Do you take Aranesp and have Pain disorder?

Check whether Pain disorder is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Pain disorder and when was it recovered:

Pain disorder in Aranesp

Expand to all the drugs that have ingredients of darbepoetin alfa:

Pain disorder and drugs with ingredients of darbepoetin alfa

Alternative drugs to, pros and cons of Aranesp:

Aranesp (50,791 reports)

Common Aranesp side effects:

Death: 14,840 reports
Fatigue (feeling of tiredness): 2,172 reports
Breathing difficulty: 1,997 reports
Pain: 1,867 reports
Weakness: 1,807 reports

Browse all side effects of Aranesp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Pain disorder treatments and more:

Pain disorder (546 reports)

COVID vaccines that are related to Pain disorder:

All the drugs that are associated with Pain disorder:

Pain disorder (416 drugs)

All the conditions that are associated with Pain disorder:

Pain disorder (246 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on darbepoetin alfa (the active ingredients of Aranesp) and Aranesp (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.